Try our new research platform with insights from 80,000+ expert users
Cloudflare Web Application Firewall Logo

Cloudflare Web Application Firewall Reviews

Vendor: Cloudflare
4.2 out of 5
Badge Leader

What is Cloudflare Web Application Firewall?

Featured Cloudflare Web Application Firewall reviews

Cloudflare Web Application Firewall mindshare

As of March 2025, the mindshare of Cloudflare Web Application Firewall in the Web Application Firewall (WAF) category stands at 7.8%, up from 6.6% compared to the previous year, according to calculations based on PeerSpot user engagement data.
Web Application Firewall (WAF)

PeerAnalyst reports based on Cloudflare Web Application Firewall reviews

TypeTitleDate
CategoryWeb Application Firewall (WAF)Mar 4, 2025Download
ProductReviews, tips, and advice from real usersMar 4, 2025Download
ComparisonCloudflare Web Application Firewall vs AWS WAFMar 4, 2025Download
ComparisonCloudflare Web Application Firewall vs Microsoft Azure Application GatewayMar 4, 2025Download
ComparisonCloudflare Web Application Firewall vs F5 Advanced WAFMar 4, 2025Download
Suggested products
TitleRatingMindshareRecommending
Microsoft Azure Application Gateway3.610.1%78%47 interviewsAdd to research
Azure Front Door4.44.4%100%14 interviewsAdd to research
 
 
Key learnings from peers

Valuable Features

Room for Improvement

Pricing

Popular Use Cases

Service and Support

Deployment

Scalability

Stability

Review data by company size

By reviewers
By visitors reading reviews

Top industries

By visitors reading reviews
Educational Organization
27%
Computer Software Company
13%
Financial Services Firm
8%
Comms Service Provider
5%
Manufacturing Company
5%
Construction Company
4%
Government
4%
Media Company
4%
Retailer
3%
Insurance Company
3%
Real Estate/Law Firm
3%
Energy/Utilities Company
3%
Healthcare Company
3%
University
2%
Hospitality Company
2%
Non Profit
2%
Outsourcing Company
1%
Consumer Goods Company
1%
Wholesaler/Distributor
1%
Recreational Facilities/Services Company
1%
Legal Firm
1%
Transportation Company
1%
Pharma/Biotech Company
1%